Molecure S.A. (WSE:MOC)
5.35
+0.01 (0.19%)
May 21, 2026, 5:02 PM CET
Molecure Revenue
In the year 2025, Molecure had annual revenue of 6.52M PLN with 123.34% growth. Molecure had revenue of 2.95M in the quarter ending December 31, 2025, with 29.02% growth.
Revenue
6.52M
Revenue Growth
+123.34%
P/S Ratio
16.88
Revenue / Employee
91.82K
Employees
71
Market Cap
110.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.52M | 3.60M | 123.34% |
| Dec 31, 2024 | 2.92M | -733.54K | -20.08% |
| Dec 31, 2023 | 3.65M | -3.86M | -51.39% |
| Dec 31, 2022 | 7.51M | 6.35M | 543.32% |
| Dec 31, 2021 | 1.17M | -123.74M | -99.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 282.52M |
| Synthaverse | 42.01M |
| Mabion | 15.76M |
| Captor Therapeutics Spolka Akcyjna | 4.66M |
| Urteste | 1.80M |
| Pharmena | 1.58M |
| Poltreg | 250.00K |
| NanoGroup | -6.90K |
Molecure News
- 3 days ago - Molecure Quarterly report: Q1 2026 - Filings
- 2 months ago - Molecure Annual report: Q4 2025 - Filings
- 7 months ago - Molecure Quarterly report: Q3 2025 - Filings
- 8 months ago - Molecure Quarterly report: Q2 2025 - Filings
- 1 year ago - Molecure Earnings Call Transcript: Q4 2024 - Transcripts